|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, May 14, 2018 ) Plasma Fractionation Market was worth USD 19.4 billion in 2016 and is projected to be growing at a CAGR of 7.2%, to touch USD 27.46 billion by 2021. Blood fractionation is the process of fractionating whole blood or segregating it into its constituent parts. Whole blood consists of red cells, white cells, and platelets, suspended in plasma, which constitutes about 55% of blood by volume.
Browse For Full Report @ https://www.marketdataforecast.com/market-reports/plasma-fractionation-market-2837/
Plasma is the liquid portion of blood. It not only consists of red cells, white cells and platelets suspended in it, but also contains thousands of distinct proteins and other substances like electrolytes, minerals, hormones, etc., which are necessary for the normal function of the human body. Plasma helps in maintaining blood pressure and body temperature regulation.
Request Sample Report @ https://www.marketdataforecast.com/market-reports/plasma-fractionation-market-2837/request-sample
The growth of the Global Plasma Fractionation Market is mainly driven by factors such as increasing incidence of immune and bleeding disorders, growing incidence of Alpha-1 Antitrypsin deficiency and the rising use of immunoglobulins, which are basically antibodies. Further, growing aging population with related blood related ailments is set to further drive market growth. However, adverse reactions associated with the use of plasma fractionation and transfer, high costs of plasma products and unfavourable reimbursement policies are the major constraints of market growth.
The Global Plasma Fractionation Market is segmented on the basis of Product, Application, End User and Geography. Based on Product, the market is divided into Albumin, Immunoglobulin, Factor VIII, and Protease Inhibitors. Based on Application, the Plasma Fractionation Market is segmented into Neurology, Haematology, Rheumatology, Pulmonology, and Immunology. Based on the End User, it is categorized into Hospital and Clinical Laboratories.
Inquire Before Buy @ https://www.marketdataforecast.com/market-reports/plasma-fractionation-market-2837/inquire
The market has been geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. As of 2016, North America leads the market, with the U.S. accounting for a major share. North America’s lead is justified by the presence of high number of registered haemophilic patients and increasing use of immunoglobulins in neurologic disorders. Europe comes in second in terms of market share owing to the rising awareness about blood related disorders and the swift availability of treatment in terms of plasma fractionation. However, Asia-Pacific is estimated to grow at the highest CAGR during the forecast period majorly because of the presence of larger elderly population numbers leading to higher incidence of blood disorders.
Buy Now @ https://www.marketdataforecast.com/cart/buy-now/plasma-fractionation-market-2837
The major players in the Plasma Fractionation market are CSL Ltd. (Australia), Grifols S.A (Spain), Baxalta Incorporated (U.S.), Octapharma AG (Switzerland), Kedrion S.p.A (Italy), Bio Products Laboratory (U.K.), Sanquin (Netherland), China Biologic Products, Inc. (China), Biotest AG (Germany), and Laboratoire Français du Fractionnement et des Biotechnologies (France).
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Market Data Forecast.
Abhishek Shukla
18887029626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
